Thomas E. Jenkins
Fondatore presso Elysium Therapeutics, Inc.
Profilo
Thomas E.
Jenkins is the founder of Elysium Therapeutics, Inc. which is founded in 2013, where he holds the title of Chief Scientific Officer.
He also held the position of Chief Scientific Officer & Vice President-Research at Signature Therapeutics, Inc. In terms of education, Jenkins holds a doctorate from Stanford University and an undergraduate degree from the University of Akron.
Posizioni attive di Thomas E. Jenkins
| Società | Posizione | Inizio |
|---|---|---|
Elysium Therapeutics, Inc.
 Elysium Therapeutics, Inc. BiotechnologyHealth Technology Elysium Therapeutics, Inc. develops pain relievers. The company was founded by Alex Gregory Sturmer and Thomas E. Jenkins in 2013 and is headquartered in Akron, OH. | Fondatore | 01/01/2013 |
Precedenti posizioni note di Thomas E. Jenkins
| Società | Posizione | Fine |
|---|---|---|
Signature Therapeutics, Inc.
 Signature Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Signature Therapeutics, Inc. develops and manufactures pharmaceutical products. It focuses on developing medications for use in pain management and ADHD. Its proprietary BIO-MD platform is designed to deter prescription drug abuse by virtue of strong chemical bonds within the prodrug and also offers solution to the ongoing epidemic of prescription opioid drug abuse. The company was founded by Steven L. Shafer in 2004 and is headquartered in Palo Alto, CA. | Direttore Tecnico/Scientifico/R&S | - |
Formazione di Thomas E. Jenkins
| University of Akron | Undergraduate Degree |
| Stanford University | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 2 |
|---|---|
Signature Therapeutics, Inc.
Signature Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Signature Therapeutics, Inc. develops and manufactures pharmaceutical products. It focuses on developing medications for use in pain management and ADHD. Its proprietary BIO-MD platform is designed to deter prescription drug abuse by virtue of strong chemical bonds within the prodrug and also offers solution to the ongoing epidemic of prescription opioid drug abuse. The company was founded by Steven L. Shafer in 2004 and is headquartered in Palo Alto, CA. | Health Technology |
Elysium Therapeutics, Inc.
Elysium Therapeutics, Inc. BiotechnologyHealth Technology Elysium Therapeutics, Inc. develops pain relievers. The company was founded by Alex Gregory Sturmer and Thomas E. Jenkins in 2013 and is headquartered in Akron, OH. | Health Technology |
- Borsa valori
- Insiders
- Thomas E. Jenkins
